These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14522571)

  • 1. Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender.
    Holven KB; Myhre AM; Aukrust P; Hagve TA; Ose L; Nenseter MS
    Eur Heart J; 2003 Oct; 24(19):1756-62. PubMed ID: 14522571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES.
    Holven KB; Damås JK; Yndestad A; Waehre T; Ueland T; Halvorsen B; Heggelund L; Sandberg WJ; Semb AG; Frøland SS; Ose L; Nenseter MS; Aukrust P
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):200-5. PubMed ID: 16254204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia.
    Narverud I; Halvorsen B; Nenseter MS; Retterstøl K; Yndestad A; Dahl TB; Ulven SM; Olstad OK; Ose L; Holven KB; Aukrust P
    J Intern Med; 2013 Jan; 273(1):69-78. PubMed ID: 22891927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial Changes in Chemokines Related to Early Atherosclerotic Processes in Familial Hypercholesterolemic Subjects: A Preliminary Study.
    Cortes R; Ivorra C; Martínez-Hervás S; Pedro T; González-Albert V; Artero A; Adam V; García-García AB; Ascaso JF; Real JT; Chaves FJ
    Arch Med Res; 2016 Jan; 47(1):33-9. PubMed ID: 26820799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins.
    Escate R; Padro T; Borrell-Pages M; Suades R; Aledo R; Mata P; Badimon L
    J Cell Mol Med; 2017 Mar; 21(3):487-499. PubMed ID: 27680891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
    Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
    Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia.
    Banyai M; Lupattelli G; Li SR; Pongratz S; Yang Q; Böck P; Angelberger P; Virgolini I
    Eur J Nucl Med; 1994 Jul; 21(7):634-9. PubMed ID: 7957349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intima-media thickness correlates with features of metabolic syndrome in young people with a clinical diagnosis of familial hypercholesterolaemia.
    Waluś-Miarka M; Wojciechowska W; Miarka P; Kloch-Badełek M; Woźniakiewicz E; Czarnecka D; Sanak M; Małecki M; Idzior-Waluś B
    Kardiol Pol; 2013; 71(6):566-72. PubMed ID: 23797428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
    Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia.
    Nielsen MH; Irvine H; Vedel S; Raungaard B; Beck-Nielsen H; Handberg A
    Oxid Med Cell Longev; 2016; 2016():2492858. PubMed ID: 26925191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL.
    Artieda M; Cenarro A; Junquera C; Lasierra P; Martínez-Lorenzo MJ; Pocoví M; Civeira F
    FEBS Lett; 2005 Aug; 579(20):4503-12. PubMed ID: 16083882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of peripheral vascular disease in familial hypercholesterolaemia.
    Kroon AA; Ajubi N; van Asten WN; Stalenhoef AF
    J Intern Med; 1995 Nov; 238(5):451-9. PubMed ID: 7595185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.
    Narverud I; Retterstøl K; Iversen PO; Halvorsen B; Ueland T; Ulven SM; Ose L; Aukrust P; Veierød MB; Holven KB
    Atherosclerosis; 2014 Aug; 235(2):299-309. PubMed ID: 24908240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Halvorsen B; Ose L; Aukrust P; Holven KB
    Cytokine; 2013 Jan; 61(1):194-8. PubMed ID: 23131422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.